Trial NCT02134912

View at ClinicalTrials.gov 
Org. Study IDs: S1300
Secondary IDs: NCI-2014-00685 S1300 U10CA032102 U10CA180888

Last trial update was posted on 2020-02-20

MeSH Interventions

Crizotinib Pemetrexed Tyrosine Kinase Inhibitors

MeSH Conditions

Adenocarcinoma of Lung Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Adenocarcinoma of the Lung Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Stopping Reasons

science has moved forward and there is no intent to complete the study

Limitations And Caveats

The one patient that enrolled immediately withdrew consent [enrolled the day before the study closed]. No manuscript will be forthcoming.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID